Hapuarachchige Surangi N. Jayawardena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hapuarachchige Surangi N. Jayawardena has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Mingdi Yan
University of Massachusetts Lowell
9 shared publications Kalana W. Jayawardana
Department of Biomedical Engineering Vanderbilt University Nashville Tennessee 37235 USA
6 shared publicationsXuan Chen
Department of Chemistry, University of Massachusetts Lowell, 1 University Ave, Lowell, MA 01854, United States
5 shared publications- Ana Jaklenec
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA
4 shared publications Madanodaya Sundhoro
Department of Chemistry, University of Massachusetts Lowell, 1 University Ave, Lowell, MA 01854, United States
4 shared publications- Robert Langer
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, USA
4 shared publications
Latest Publications
- Open Access
- 10 March 2021
- Published by Wiley in Nano Select
- Vol. 2 (9) , 1750-1769
Near‐infrared responsive targeted drug delivery system that offer chemo‐photothermal therapy against bacterial infection
To combat the rise of antibiotic resistant bacteria, it is essential to look upon other therapeutic solutions that do not solely depend upon conventional antibiotics. Here, we have designed a combinational therapeutic approach that kills bacteria with the conjunction of photothermal (PT) and antibiotic therapy. A near‐infrared (NIR) laser activated targeted drug delivery nano‐assembly delivers antibiotic as well as offer PT therapy (PTT). The synergistic application of both therapies increases the efficacy of treatment. The protected delivery of antibiotic and its release in the proximity of the bacteria surface reduces off‐target toxicity and reduce the efficacious dosage. Core of the nano‐assembly is composed of NIR active gold nanorods (GNRs) coated with a mesoporous silica nanoparticle (MSNP), which serves as a carrier for an anti‐tuberculosis drug bedaquiline (BDQ). The assembly was wrapped within a thermo‐sensitive liposome (TSL) conjugated to mycobacteria‐targeting peptide: NZX, GNR@MSNP@BDQ@TSL@NZX. NZX mediates adhesion of final nano‐assembly on mycobacteria surface. Upon NIR laser irradiation GNRs convert photo energy of the laser to localized heat, which melts TSL triggering release of BDQ. Antibacterial activity of final nano‐assembly against Mycobacterium smegmatis (Msmeg) was 20 folds more efficacious than the free drug equivalent. The final nano‐assembly could also successfully inhibit the growth of intracellular mycobacteria residing in lung cells.
- 10 March 2021
- Published by Wiley in Nano Select
- Vol. 2 (9) , 1750-1769
Open AccessNear‐infrared responsive targeted drug delivery system that offer chemo‐photothermal therapy against bacterial infection
To combat the rise of antibiotic resistant bacteria, it is essential to look upon other therapeutic solutions that do not solely depend upon conventional antibiotics. Here, we have designed a combinational therapeutic approach that kills bacteria with the conjunction of photothermal (PT) and antibiotic therapy. A near‐infrared (NIR) laser activated targeted drug delivery nano‐assembly delivers antibiotic as well as offer PT therapy (PTT). The synergistic application of both therapies increases the efficacy of treatment. The protected delivery of antibiotic and its release in the proximity of the bacteria surface reduces off‐target toxicity and reduce the efficacious dosage. Core of the nano‐assembly is composed of NIR active gold nanorods (GNRs) coated with a mesoporous silica nanoparticle (MSNP), which serves as a carrier for an anti‐tuberculosis drug bedaquiline (BDQ). The assembly was wrapped within a thermo‐sensitive liposome (TSL) conjugated to mycobacteria‐targeting peptide: NZX, GNR@MSNP@BDQ@TSL@NZX. NZX mediates adhesion of final nano‐assembly on mycobacteria surface. Upon NIR laser irradiation GNRs convert photo energy of the laser to localized heat, which melts TSL triggering release of BDQ. Antibacterial activity of final nano‐assembly against Mycobacterium smegmatis (Msmeg) was 20 folds more efficacious than the free drug equivalent. The final nano‐assembly could also successfully inhibit the growth of intracellular mycobacteria residing in lung cells.
- Top Cited Papers
- 12 January 2021
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 93 (4) , 1889-1911
Analytical Methods for Characterization of Nanomaterial Surfaces
- 12 January 2021
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 93 (4) , 1889-1911
Top Cited PapersAnalytical Methods for Characterization of Nanomaterial Surfaces
- 19 July 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (10) , 6708-6721
Targeted Delivery of Antibiotic Therapy to Inhibit Pseudomonas aeruginosa Using Lipid-Coated Mesoporous Silica Core–Shell Nanoassembly
Pseudomonas aeruginosa (PA) is an opportunistic pathogen which causes serious lung infections in immunocompromised patients. Traditional oral intake of large quantities of small molecule antibiotics to treat bacterial infections leads to off-target toxicity and development of drug resistant species. Improved delivery systems of antibiotics to the targeted site of bacterial infections would help reduce the need for a high intake of antibiotics. Colistin (Col), an antibacterial peptide, is considered the last resort treatment for multi drug resistant (MDR)-PA. To approach the problem of development of antibacterial resistance and off target toxicity due to the use of excessive amounts of antibiotics, we have designed a targeted drug delivery nanoassembly which deliver antibiotics to extracellular and intracellular bacteria. The nanoassembly is composed of (1) drug (Col) loaded mesoporous silica (MSN) core ([email protected]), (2) liposomal shell ([email protected]@LL) (3) PA-targeting LL-37 peptide ([email protected]@LL-(LL37)). The liposomal shell prevents premature drug release before the nanoassembly approach the targeted bacteria. The liposome bilayer degrades upon excreted lipase present in the local environment of PA, releasing encapsulated Col. There is a significant increase in Col release (~90% release within 40 h) in the presence of bacteria compared to absence of bacteria (only ~75% release after 80 h). A 6.7-fold increase in antimicrobial efficacy of Col encapsulated in [email protected]@LL-(LL37) was seen compared to free Col. All studies were done using a clinical strain of PA14. [email protected]@LL-(LL37) successfully targets and inhibits intracellular PA14 within lung epithelial cells. Only 7% PA14 viability is seen after treating the lung epithelial cells with [email protected]@LL-(LL37). No significant cytotoxicity was observed with [email protected]@LL-(LL37). Therefore, this discussed lipid coated targeted nanoassembly can be considered as a successful antibiotic delivery platform.
- 19 July 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (10) , 6708-6721
Targeted Delivery of Antibiotic Therapy to Inhibit Pseudomonas aeruginosa Using Lipid-Coated Mesoporous Silica Core–Shell Nanoassembly
Pseudomonas aeruginosa (PA) is an opportunistic pathogen which causes serious lung infections in immunocompromised patients. Traditional oral intake of large quantities of small molecule antibiotics to treat bacterial infections leads to off-target toxicity and development of drug resistant species. Improved delivery systems of antibiotics to the targeted site of bacterial infections would help reduce the need for a high intake of antibiotics. Colistin (Col), an antibacterial peptide, is considered the last resort treatment for multi drug resistant (MDR)-PA. To approach the problem of development of antibacterial resistance and off target toxicity due to the use of excessive amounts of antibiotics, we have designed a targeted drug delivery nanoassembly which deliver antibiotics to extracellular and intracellular bacteria. The nanoassembly is composed of (1) drug (Col) loaded mesoporous silica (MSN) core ([email protected]), (2) liposomal shell ([email protected]@LL) (3) PA-targeting LL-37 peptide ([email protected]@LL-(LL37)). The liposomal shell prevents premature drug release before the nanoassembly approach the targeted bacteria. The liposome bilayer degrades upon excreted lipase present in the local environment of PA, releasing encapsulated Col. There is a significant increase in Col release (~90% release within 40 h) in the presence of bacteria compared to absence of bacteria (only ~75% release after 80 h). A 6.7-fold increase in antimicrobial efficacy of Col encapsulated in [email protected]@LL-(LL37) was seen compared to free Col. All studies were done using a clinical strain of PA14. [email protected]@LL-(LL37) successfully targets and inhibits intracellular PA14 within lung epithelial cells. Only 7% PA14 viability is seen after treating the lung epithelial cells with [email protected]@LL-(LL37). No significant cytotoxicity was observed with [email protected]@LL-(LL37). Therefore, this discussed lipid coated targeted nanoassembly can be considered as a successful antibiotic delivery platform.
- 18 December 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (523)
Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination
Near-infrared fluorescent microparticles administered to the skin via dissolvable microneedle patches can record vaccine delivery.
- 18 December 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (523)
Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination
Near-infrared fluorescent microparticles administered to the skin via dissolvable microneedle patches can record vaccine delivery.
- 7 May 2018
- Published by Wiley in Advanced Healthcare Materials
- Vol. 7 (14) , e1800220
Evaporative Cooling Hydrogel Packaging for Storing Biologics Outside of the Cold Chain
Stabilizing thermolabile pharmaceuticals outside of the cold chain has the potential to alleviate some of the logistical and monetary burden of providing health care access in the developing world. Evaporative cooling hydrogel packaging is designed to extend the storage stability of existing pharmaceutical products without the need for reformulation. Hydrogels with high water content and reversible hydrophilicity offer a promising platform for reducing storage temperatures without refrigeration. As a model, poly(N‐isopropylacrylamide) is selected as a basis for creating a potentially low cost and easy‐to‐fabricate hydrogels.
- 7 May 2018
- Published by Wiley in Advanced Healthcare Materials
- Vol. 7 (14) , e1800220
Evaporative Cooling Hydrogel Packaging for Storing Biologics Outside of the Cold Chain
Stabilizing thermolabile pharmaceuticals outside of the cold chain has the potential to alleviate some of the logistical and monetary burden of providing health care access in the developing world. Evaporative cooling hydrogel packaging is designed to extend the storage stability of existing pharmaceutical products without the need for reformulation. Hydrogels with high water content and reversible hydrophilicity offer a promising platform for reducing storage temperatures without refrigeration. As a model, poly(N‐isopropylacrylamide) is selected as a basis for creating a potentially low cost and easy‐to‐fabricate hydrogels.
- 22 February 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (18) , e1706356
Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents
Approximately 1.7 million new cases of cancer will be diagnosed this year in the United States leading to 600 000 deaths. Patient survival rates are highly correlated with the stage of cancer diagnosis, with localized and regional remission rates that are much higher than for metastatic cancer. The current standard of care for many solid tumors includes imaging and biopsy with histological assessment. In many cases, after tomographical imaging modalities have identified abnormal morphology consistent with cancer, surgery is performed to remove the primary tumor and evaluate the surrounding lymph nodes. Accurate identification of tumor margins and staging are critical for selecting optimal treatments to minimize recurrence. Visible, fluorescent, and radiolabeled small molecules have been used as contrast agents to improve detection during real‐time intraoperative imaging. Unfortunately, current dyes lack the tissue specificity, stability, and signal penetration needed for optimal performance. Quantum dots (QDs) represent an exciting class of fluorescent probes for optical imaging with tunable optical properties, high stability, and the ability to target tumors or lymph nodes based on surface functionalization. Here, state‐of‐the‐art biocompatible QDs are compared with current Food and Drug Administration approved fluorophores used in cancer imaging and a perspective on the pathway to clinical translation is provided.
- 22 February 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (18) , e1706356
Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents
Approximately 1.7 million new cases of cancer will be diagnosed this year in the United States leading to 600 000 deaths. Patient survival rates are highly correlated with the stage of cancer diagnosis, with localized and regional remission rates that are much higher than for metastatic cancer. The current standard of care for many solid tumors includes imaging and biopsy with histological assessment. In many cases, after tomographical imaging modalities have identified abnormal morphology consistent with cancer, surgery is performed to remove the primary tumor and evaluate the surrounding lymph nodes. Accurate identification of tumor margins and staging are critical for selecting optimal treatments to minimize recurrence. Visible, fluorescent, and radiolabeled small molecules have been used as contrast agents to improve detection during real‐time intraoperative imaging. Unfortunately, current dyes lack the tissue specificity, stability, and signal penetration needed for optimal performance. Quantum dots (QDs) represent an exciting class of fluorescent probes for optical imaging with tunable optical properties, high stability, and the ability to target tumors or lymph nodes based on surface functionalization. Here, state‐of‐the‐art biocompatible QDs are compared with current Food and Drug Administration approved fluorophores used in cancer imaging and a perspective on the pathway to clinical translation is provided.
- 1 August 2017
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 500, 1-8
Poly(HEMA- co -HEMA-PFPA): Synthesis and preparation of stable micelles encapsulating imaging nanoparticles
- 1 August 2017
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 500, 1-8
Poly(HEMA- co -HEMA-PFPA): Synthesis and preparation of stable micelles encapsulating imaging nanoparticles
- 10 June 2016
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (16) , 2007-2012
Magnetic Multivalent Trehalose Glycopolymer Nanoparticles for the Detection of Mycobacteria
A multivalent trehalose‐grafted poly(lactic acid) is synthesized and encapsulated with iron oxide magnetic nanoparticles. The magnetic micelles interact with Mycobacterium smegmatis to form orange clusters. Very little particle interaction is found on Staphylococcus epidermidis 35984 or Escherichia coli ORN 208. The presented new approach to the detection of mycobacteria does not require molecular biology reagents or sophisticated instruments.
- 10 June 2016
- Published by Wiley in Advanced Healthcare Materials
- Vol. 5 (16) , 2007-2012
Magnetic Multivalent Trehalose Glycopolymer Nanoparticles for the Detection of Mycobacteria
A multivalent trehalose‐grafted poly(lactic acid) is synthesized and encapsulated with iron oxide magnetic nanoparticles. The magnetic micelles interact with Mycobacterium smegmatis to form orange clusters. Very little particle interaction is found on Staphylococcus epidermidis 35984 or Escherichia coli ORN 208. The presented new approach to the detection of mycobacteria does not require molecular biology reagents or sophisticated instruments.
- Open Access
- 14 March 2016
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 52 (28) , 5053-5056
Enzyme classification using complex dynamic hemithioacetal systems
A complex dynamic hemithioacetal system was used in combination with pattern recognition methodology to classify lipases into distinct groups.
- 14 March 2016
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 52 (28) , 5053-5056
Open AccessEnzyme classification using complex dynamic hemithioacetal systems
A complex dynamic hemithioacetal system was used in combination with pattern recognition methodology to classify lipases into distinct groups.
- 25 November 2015
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 14 (3) , 1124-1130
Fabrication of carbohydrate microarrays on a poly(2-hydroxyethyl methacrylate)-based photoactive substrate
We report the fabrication of carbohydrate microarrays on a photoactive polymer, poly(HEMA-co-HEMA-PFPA), synthesized by RAFT copolymerization of 2-hydroxyethyl methacrylate (HEMA) and perfluorophenyl azide (PFPA)-derivatized HEMA (HEMA-PFPA). PFPA allows the covalent immobilization of carbohydrates whereas the HEMA polymer provides an antifouling surface, thus the microarrays can be used directly without pretreating the array with a blocking agent. The microarrays were prepared by spin-coating the polymer followed by printing the carbohydrates. Subsequent irradiation simultaneously immobilized the carbohydrates and crosslinked the polymer matrix. The obtained 3D carbohydrate microarrays showed enhanced fluorescence signals upon treating with a fluorescent lectin in comparison with a 2D microarray. The signals were acquired at a lower lectin concentration and a shorter incubation time. When treated with E. coli bacteria, the carbohydrate microarray showed results that were consistent with their binding patterns.
- 25 November 2015
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 14 (3) , 1124-1130
Fabrication of carbohydrate microarrays on a poly(2-hydroxyethyl methacrylate)-based photoactive substrate
We report the fabrication of carbohydrate microarrays on a photoactive polymer, poly(HEMA-co-HEMA-PFPA), synthesized by RAFT copolymerization of 2-hydroxyethyl methacrylate (HEMA) and perfluorophenyl azide (PFPA)-derivatized HEMA (HEMA-PFPA). PFPA allows the covalent immobilization of carbohydrates whereas the HEMA polymer provides an antifouling surface, thus the microarrays can be used directly without pretreating the array with a blocking agent. The microarrays were prepared by spin-coating the polymer followed by printing the carbohydrates. Subsequent irradiation simultaneously immobilized the carbohydrates and crosslinked the polymer matrix. The obtained 3D carbohydrate microarrays showed enhanced fluorescence signals upon treating with a fluorescent lectin in comparison with a 2D microarray. The signals were acquired at a lower lectin concentration and a shorter incubation time. When treated with E. coli bacteria, the carbohydrate microarray showed results that were consistent with their binding patterns.